Lupin Limited

Lupin Limited is Hiring Quality Control Manager (M1)

Job Description

Position – Quality Control Manager (M1)

Experience – 12 to 16 Years

Education – B. Pharma / M.Sc

Location – Pithampur, Madhya Pradesh

Note- Stability of minimum 2 to 3 years in each organization worked.
 

Responsibilities :

Must have worked in Nasal formulation

Able to handle the QC Team & all the activities carried out in QC Lab

Able to handle Investigation and QAMS activity
 

Requirements :

Good Communication & Presentation Skill

Interpersonal Skill

Have worked in USFDA plant

Analytical though process

Decision Making Skill

 

 

 

 

Job Overview

  • Posted Date : 27-Aug-2024
  • Location : Pithampur
  • Qualification : B.Pharm / M.Sc
  • Experience : 12-16 Years
  • Company : Lupin Limited

Increase your chances of getting hired, get your resume reviewed by an industry expert ..! click here

Company Information

Lupin's journey serves as a tribute to the creative potential, empathy, and undying desire for a better tomorrow in humankind. Since its founding in 1968 by the visionary Dr. Desh Bandhu Gupta, Lupin has grown from modest beginnings to become a pioneer in the world of healthcare. With our headquarters in Mumbai, India, we have grown throughout the United States, Latin America, Asia, and Europe. We now operate in more than 100 countries and provide a wide range of products, numbering in the thousands. Lupin is steadfast in its pursuit of its goal of ensuring that everyone has access to high-quality healthcare, drawing inspiration from the hardy lupin flower that thrives in harsh environments and nourishes the earth. We understand how critical it is to support the communities we work with and make a constructive contribution to society.

Lupin's extensive global manufacturing network enables us to provide our clients with products that are guaranteed to be of high quality. The objective of producing quality, reasonably priced medications that fulfill unmet patient requirements is shaped by our investments in manufacturing capital. We keep increasing automation and capacity to support our pipeline of sophisticated generics and biotechnology items in accordance with our growth strategy.

The high-potency product manufacturing block at Indore Unit I, the cutting-edge Metered Dose Inhalers (MDI) plant at Indore Unit III, the Pyrazinamide API block at the Visakhapatnam unit, the new, cutting-edge facility for Oral Solid Dose (OSD) formulations and injectables at the Nagpur SEZ unit, and the multiplication of our Biotech Drug Substance facility in Pune are just a few of the new areas we have recently created capacities in.